A Case Report of Cronkhite-Canada Syndrome in Conjunction with Sigmoid Colon and Early Esophageal Cancers
-
By
-
Wang, Yumeng
-
孙, 文妍
-
王, 鼎鑫
-
Fan, QIcheng
-
Huang, Zhihang
-
Bai, Yun
-
April 6, 2026
-
Clinical Scorecard: A Case Report of Cronkhite-Canada Syndrome in Conjunction with Sigmoid Colon and Early Esophageal Cancers
At a Glance
| Category | Detail |
|---|
| Condition | Cronkhite-Canada Syndrome (CCS) |
| Key Mechanisms | Characterized by gastrointestinal polyps, diarrhea, hair loss, and malnutrition. |
| Target Population | Patients with Cronkhite-Canada syndrome and associated malignancies. |
| Care Setting | Oncology and gastroenterology clinics. |
Key Highlights
- Simultaneous diagnosis of CCS, sigmoid colon cancer, and early esophageal cancer.
- Radical resection of sigmoid colon cancer followed by hormone therapy.
- Symptoms of diarrhea, hair loss, and malnutrition improved post-treatment.
- Reduction in gastric-duodenal and colonic polyp-like lesions observed.
- No active treatment for early esophageal cancer during 3 years of follow-up.
Guideline-Based Recommendations
Diagnosis
- Diagnosis of CCS should include evaluation of gastrointestinal symptoms and polyp formation.
Management
- Radical resection of associated cancers is recommended when feasible.
Monitoring & Follow-up
- Long-term follow-up for early esophageal cancer is essential.
Risks
- Increased risk of gastrointestinal malignancies in patients with CCS.
Patient & Prescribing Data
Patients diagnosed with Cronkhite-Canada syndrome and concurrent cancers.
Hormone therapy may alleviate symptoms and reduce polyp-like lesions.
Clinical Best Practices
- Multidisciplinary approach for management of CCS and associated cancers.
- Regular monitoring for gastrointestinal symptoms and cancer development.
References
